Literatur
- 01 Martens J, Egerer G, Shin W et al. Caspofungin use in daily clinical practice for
treatment of invasive Aspergillosis: results of a prospective observational registry.
ECCMID 2008; poster 1017.
- 02 Viscoli C, Herbrecht R, Akan H et al. A multicenter, open, phase II study to estimate
the acitivity and safety of caspofungin in the first-line therapy of probable and
proven invasive aspergillosis in patients with hematological malignancies or recipients
of autologous HSCT - EORTC 65041.
01 European Organisation for Research and Treatment of Cancer
